Yuliya Rueb
CIK: 0002125370
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TYRA
Tyra Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Rueb Yuliya
Rueb Yuliya (SEC CIK 0002125370) files insider reports with the SEC as Vice President, Finance (PAO) of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 3 ownership filings by Rueb Yuliya (1 Form 3, 2 Form 4), filed between Apr 2, 2026 and Sep 17, 2026. Those filings report 2 transactions, from May 5, 2026 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rueb Yuliya's filings is in CARLSBAD, CA.
Recent filings by Rueb Yuliya
Other insiders filing for Tyra Biosciences, Inc. (TYRA)
- Harris Todd, President and CEO
- Fuhrman Alan, Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Verjee Rehan, Director
- Moran Susan, Director
- Simson Jake, Director